MabThera is the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface. These cells are central to many blood cancers, including common forms of lymphoma and leukaemia. MabThera attacks these cells both directly and together with the body’s immune system.
Read MoreRevlimid (lenalidomide) affects the immune system. It promotes immune responses to help slow tumor growth.
Read MoreTagrisso is medicine for treating a lung cancer called non-small cell lung cancer (NSCLC) when the cancer is advanced or has spread. It contains the active substance osimertinib.
Read MoreVelbe injection contains the active ingredient vinblastine, which is a type of chemotherapy medicine called a vinka alkaloid. It is used to treat various types of lymphomas, as well as some solid tumours.
Read MoreYondelis (trabectedin) is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Read MoreZepatier contains a combination of elbasvir and grazoprevir. Elbasvir and grazoprevir are antiviral medicines that prevent hepatitis C (HCV) from multiplying in your body. Zepatier is used to treat chronic hepatitis C in adults.
Read MoreZometa (zolcdronic acid) Injection is a bisphosphonate used to treat Paget's disease, high blood levels of calcium caused by cancer (hypercalcemia of malignancy), multiple myeloma (a type of bone marrow cancer), or metastatic bone cancer. Zometa is also used to treat or prevent osteoporosis in postmenopausal women, and to increase bone mass in men with osteoporosis.
Read MoreZydelig (Idelalisib) is a type of targeted cancer drug (biological therapy).
Read More